Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Surgical Removal of Fallopian Tubes to Prevent Ovarian Cancer Rapidly Rising, More Research Needed to Support Its Continued Use

July 14th 2020, 1:22am

Article

Ten percent of women who received a hysterectomy and salpingectomy, or removal of the fallopian tubes, during the study period had a family history of breast or ovarian cancer.

Certain Recurring Symptoms May Be Linked to Ovarian Cancer

July 13th 2020, 10:00pm

Article

A recent data analysis found that most women diagnosed with ovarian cancer (92%) experienced abdominal and pelvic-related symptoms and visited a physician with this complaint anywhere from six to 70 months prior to diagnosis.

Expert Discusses Therapeutic Options Taken At Home During COVID-19 Pandemic

July 7th 2020, 7:55pm

Article

Dr. Jubilee Brown discussed the use of telemedicine and oral treatment options for patients with ovarian cancer, as well as offered advice to ease stress and anxiety throughout the COVID-19 pandemic.

Combination of Mirvetuximab Soravtansine and Avastin Demonstrates Effective Outcomes in Recurrent Ovarian Cancer

June 15th 2020, 7:25pm

Article

The combination of mirvetuximab soravtansine and Avastin (bevacizumab) demonstrated encouraging overall response rates in patients with ovarian cancer, regardless of the disease’s previous responsiveness to platinum-based chemotherapy, according to data presented at the 2020 ASCO Virtual Scientific Program.

Lynparza-Cediranib Combination Produces Similar Activity to Standard of Care Chemotherapy in Ovarian Cancer

June 11th 2020, 1:00am

Article

The presentation of the complete data from the NRG-GY004 trial comes just months after AstraZeneca and Merck announced in a press release that the combination failed to meet its primary endpoint of progression-free survival.

CURE's Top Stories: May 2020

June 2nd 2020, 1:10am

Article

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for May 2020.

Finding Meaning While Waiting in the Infusion Chair

May 23rd 2020, 6:00pm

Article

One survivor makes the most of the time in the infusion chair, creating beaded jewelry and helping herself and others to heal.

Teal on Wheels: Riding to Raise Ovarian Cancer Awareness

May 21st 2020, 7:00pm

Podcast

In this episode of the “CURE Talks Cancer” podcast, we spoke with a cervical cancer survivor - who is currently living with ovarian cancer - about a cross-country journey she took last summer on a teal and white Harley Davidson motorcycle to raise ovarian cancer awareness.

What You Need to Know About the FDA's Approval of Lynparza and Avastin for Advanced Ovarian Cancer

May 21st 2020, 1:00am

Article

The Food and Drug Administration recently approved the combination of Lynparza (olaparib) and Avastin (bevacizumab) for patients with advanced ovarian cancer that carries a specific mutation and has responded to previous treatment with platinum-based chemotherapy plus Avastin. Here’s what you need to know.

FDA's Approval of Zejula Offers Patients with High-Grade Ovarian Cancer a Maintenance Therapy Option

May 20th 2020, 1:00am

Article

The Food and Drug Administration’s recent approval of Zejula is different from previous approvals as it is indicated for all patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer, according to a gynecologic oncology expert.